Loading

JSM Hepatitis

Downolad Brochure

2016 - Volume 1 - Issue 1 Articles

Discontinuation of Long-Term Nucleos(T)ide Analogue (NA) Therapy in HBeAg-Negative Chronic Hepatitis B (CHB). Is it Feasible Strategy in 2016?

Editorial | Article
By George Kontos Hariklia Kranidioti Melanie Deutsch Spilios Manolakopoulos

April 19, 2016 | Pages : 205 - 450

Abstract
- Abstract
- EPub
- XML
- Full text
- PDF
Nafld and Increased Risk of Cardiac Complications: Myth or Realty?

Editorial | Article
By Alessandro Mantovani

April 20, 2016 | Pages : 205 - 450

Abstract
- Abstract
- EPub
- XML
- Full text
- PDF
Interleukin-33 and its Soluble Receptor ST2 as Non-Invasive Biomarkers of Human Hepatitis

Editorial | Article
By Claire PiquetPellorce Hilal Ahmad Khan Michel Samson Muhammad Imran Arshad

May 13, 2016 | Pages : 205 - 450

Abstract
- Abstract
- EPub
- XML
- Full text
- PDF
Hepatitis B Occult Infection in Indigenous Populations from Latin America

Review Article | Article
By Isabelle Chemin Carmen Luisa Loureiro Flor H. Pujol Nathalia Cardona Rossana Jaspe

July 12, 2016 | Pages : 205 - 450

Abstract Around 250 million persons are chronically infected with hepatitis B virus (HBV) worldwide, and this infection may lead to cirrhosis and Hepatocellular carcinoma (HCC). HBV can circulate as an occult infection (OBI), with the absence of the classical.....
- Abstract
- EPub
- XML
- Full text
Emerging Roles of Antidiabetic Drugs beyond Glucose Control: Beneficial Effects on Hepatitis and Hepatocellular Carcinoma

Review Article | Article
By Qianni Cheng

April 29, 2016 | Pages : 205 - 450

Abstract Insulin resistance and hyperglycemia in type 2 diabetes mellitus (T2DM) are both correlated with hepatitis and hepatocyte carcinoma. Thiazolidinediones and biguanides, belong to insulin sensitizers, are front-line antidiabetic drugs. DPP-4 inhibitors.....
- Abstract
- EPub
- XML
- Full text
- PDF